xanomeline has been researched along with pilocarpine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abuh, YF; Dunbar, PG; Edgar, MA; El-Assadi, AA; Fang, Z; Huzl, JJ; Liu, Y; Messer, WS; Nagy, PI; Ngur, DO; Ojo, B; Periyasamy, S; Rho, T; Roknich, S; Sbeih, S; Zhang, H | 1 |
| Bymaster, FP; Calligaro, DO; DeLapp, NW; Fink-Jensen, A; Jeppesen, L; Olesen, PH; Rasmussen, T; Rimvall, K; Sauerberg, P; Shannon, HE; Sheardown, MJ; Thomsen, C; Ward, JS; Whitesitt, CA | 1 |
| El-Fakahany, EE; Grant, MK | 1 |
| Dei, S; Marconi, C; Pedretti, A; Romanelli, MN; Scapecchi, S; Vistoli, G | 1 |
| Enomoto, T; Kitamura, A; Kiyoshi, A; Konishi, Y; Matsuda, H; Nakako, T; Sakai, M; Sumiyoshi, T; Suwa, A; Takahashi, Y; Takai, K; Tojo, K; Uematsu, Y; Uruno, Y | 1 |
| Bymaster, FP; Calligaro, DO; Carter, PA; DeLapp, N; Fink-Jensen, A; Jeppesen, L; Mitch, CH; Peters, SC; Rimvall, K; Sauerberg, P; Shannon, HE; Sheardown, MJ; Ward, JS; Whitesitt, CA; Zhang, W | 1 |
| Goodhead, LH; Mitchell, SN; Moss, S; Sharott, A | 1 |
| Carnicella, S; Oberling, P; Pain, L | 1 |
| El-Fakahany, EE; Grant, MK; Noetzel, MJ | 1 |
| Gmeiner, P; Hu, Y; Hübner, H; Jin, C; Kaindl, J; Kobilka, BK; Li, H; Maeda, S; Niu, X; Risel, P; Xu, J | 1 |
| Chen, H; Hou, Y; Wang, D; Wang, H; Wang, S; Xu, J; Yao, Y; Zhao, L | 1 |
11 other study(ies) available for xanomeline and pilocarpine
| Article | Year |
|---|---|
Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
Topics: Animals; Arecoline; Brain; Carbachol; Cell Line; Models, Molecular; Muscarinic Agonists; Phosphatidylinositols; Pyrimidines; Quinuclidinyl Benzilate; Rats; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptors, Muscarinic; Structure-Activity Relationship | 1997 |
Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation.
Topics: Animals; Cells, Cultured; CHO Cells; Cricetinae; Humans; Inhibitory Concentration 50; Muscarinic Agonists; Pyridines; Rats; Receptor, Muscarinic M1; Receptors, Muscarinic; Structure-Activity Relationship; Thiadiazoles; Transfection | 1998 |
Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor.
Topics: Animals; Carbachol; CHO Cells; Cricetinae; Inositol Phosphates; Muscarinic Agonists; Muscarinic Antagonists; N-Methylscopolamine; Pilocarpine; Pyridines; Receptor, Muscarinic M5; Thiadiazoles | 2005 |
Docking analyses on human muscarinic receptors: unveiling the subtypes peculiarities in agonists binding.
Topics: Binding Sites; Computer Simulation; Humans; Ligands; Muscarinic Agonists; Protein Binding; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M5; Receptors, Muscarinic | 2008 |
Discovery of novel N-substituted oxindoles as selective m1 and m4 muscarinic acetylcholine receptors partial agonists.
Topics: | 2013 |
Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.
Topics: Animals; Binding, Competitive; Brain Chemistry; Bridged Bicyclo Compounds, Heterocyclic; Cholinergic Agents; Cholinesterase Inhibitors; Dihydropyridines; Dose-Response Relationship, Drug; Hydrolysis; Hypothermia; Imines; Lithium; Male; Mice; Mice, Inbred Strains; Muscarinic Agonists; Oximes; Parasympathomimetics; Phosphatidylinositols; Physostigmine; Pilocarpine; Pyridines; Quinuclidines; Radioligand Assay; Salivation; Tacrine; Tetrazoles; Thiadiazoles; Tremor | 1998 |
Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens.
Topics: Animals; Atropine; Bicuculline; Bridged-Ring Compounds; Carbachol; Cholinergic Agonists; Diamines; Dopamine; Hippocampus; Male; Microdialysis; Muscarinic Agonists; Muscarinic Antagonists; Nicotine; Nucleus Accumbens; Oxotremorine; Pilocarpine; Pyridines; Rats; Receptors, Muscarinic; Spiro Compounds; Thiadiazoles; Tropanes | 2003 |
Cholinergic effects on fear conditioning II: nicotinic and muscarinic modulations of atropine-induced disruption of the degraded contingency effect.
Topics: Animals; Atropine; Conditioning, Classical; Fear; Male; Memory; Muscarinic Antagonists; Nicotine; Nicotinic Antagonists; Oxotremorine; Parasympathetic Fibers, Postganglionic; Pilocarpine; Psychopharmacology; Pyridines; Rats; Rats, Sprague-Dawley; Thiadiazoles | 2005 |
Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.
Topics: Animals; Atropine; Binding Sites; Carbachol; Cell Line, Transformed; Cricetinae; Drug Interactions; Female; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Muscarinic Agonists; N-Methylscopolamine; Phosphatidylinositols; Pilocarpine; Pyridines; Quinuclidinyl Benzilate; Receptor, Muscarinic M3; Thiadiazoles; Time Factors; Transfection | 2009 |
Conformational Complexity and Dynamics in a Muscarinic Receptor Revealed by NMR Spectroscopy.
Topics: Acetylcholine; Animals; Baculoviridae; Binding Sites; Carbachol; Cloning, Molecular; Gene Expression; Genetic Vectors; Humans; Isoxazoles; Kinetics; Ligands; Magnetic Resonance Spectroscopy; Molecular Dynamics Simulation; Pilocarpine; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Pyridines; Quaternary Ammonium Compounds; Receptor, Muscarinic M2; Recombinant Proteins; Sf9 Cells; Spodoptera; Thermodynamics; Thiadiazoles | 2019 |
Structural Insights into M1 Muscarinic Acetylcholine Receptor Signaling Bias between Gαq and β-Arrestin through BRET Assays and Molecular Docking.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Acetylcholine; beta-Arrestin 1; beta-Arrestin 2; beta-Arrestins; Energy Transfer; GTP-Binding Proteins; HEK293 Cells; Humans; Molecular Docking Simulation; Pilocarpine; Receptor, Muscarinic M1 | 2023 |